More Than Pathogen Reduction: Seraph 100 In COVID-19 Patients

More Than Pathogen Reduction: Seraph 100 In COVID-19 Patients

Panelists:

Professor Jan Kielstein 

(Klinikum Braunschweig, Germany) 

Doctor Julius Schmidt 

(Hannover Medical School, Germany) 

Doctor Steven Stogner 

(Forrest General Hospital in Hattiesburg, Mississippi, USA) 

Doctor Brian Rifkin 

(Forrest General Hospital in Hattiesburg, Mississippi, USA)

Find ExThera Medical On Social Media 


Exhibit

Symposia

Workshops

Organiser

Sponsor



EXTHERA

ExThera Medical was formed in 2007 through a joint venture between the Emergence Venture Partners Life Science Incubator and ExThera AB, at the Karolinska Institute of Stockholm. We are focused on therapeutic applications to treat drug-resistant and drug-susceptible bloodstream infections in high-risk patient populations, with field deployable versions for biodefense and military.


The company’s first product, the Seraph® 100 Microbind® Affinity Blood Filter, is CE Marked for the reduction of pathogens during bloodstream infections in adjunction to antibiotics and commercially available in Europe.

Registration available online here




More events

Life 2021

Tue, 15 Sep 2020 - Sat, 18 Sep 2021

AARC Congress 2020 LIVE - Live learning event

Wed, 18 Nov 2020 - Sat, 5 Dec 2020

ACEM Virtual 2020

Tue, 24 Nov 2020 - Fri, 27 Nov 2020

1st Virtual eIFAD 2020

Wed, 25 Nov 2020 - Fri, 27 Nov 2020

Euroanaesthesia 2020

Sat, 28 Nov 2020 - Mon, 30 Nov 2020

PCICS Annual International Meeting 2020

Wed, 9 Dec 2020 - Fri, 11 Dec 2020

NEUROINTENSIVE CARE: UPDATE 2021

Mon, 11 Jan 2021 - Sat, 20 Feb 2021

50th Critical Care Congress

Sun, 31 Jan 2021 - Fri, 12 Feb 2021

220-220.jpg

Fri, 19 Mar 2021 - Sat, 20 Mar 2021


Bangkok, Thailand 10310
Thailand
9th EuroELSO Congress 2021

Mon, 29 Mar 2021 - Wed, 31 Mar 2021

Related articles